Bioreactivity of resveratrol toward inflammation processes

Recent Advances in Redox Active Plant and Microbial Products: From Basic Chemistry to Widespread Applications in Medicine and Agriculture

Volumn , Issue , 2014, Pages 193-207

  Latruffe, Norbert ^a   Lançon, Allan ^a   Limagne, Emeric ^a   Michaille, Jean Jacques ^a  

^a Faculté des Sciences Gabriel   (France)

Author keywords

Cardiovascular diseases; French paradox; Functional food; Red wine; Sirtuins

Indexed keywords

EID: 84930893961     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-017-8953-0_7     Document Type: Chapter

References (43)

1. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71(10):1397-1421.
2. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ, Ambati BK (2003) An animal model of age-related macular degeneration in senescent Ccl-2-or Ccr-2- deficient mice. Nat Med 9(11):1390-1397.
3. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (2007) Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharm 224(3):274-283.
4. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang MY, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444(7117):337-342.
5. Bertelli A, Bertelli AAE, Gozzini A, Giovannini L (1998) Plasma and tissue resveratrol concentrations and pharmacological activity. Drug Exp Clin Res 24(3):133-138.
6. Bureau G, Longpre F, Martinoli MG (2008) Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res 86(2):403-410.
7. Calamini B, Ratia K, Malkowski MG, Cuendet M, Pezzuto JM, Santarsiero BD, Mesecar AD (2010) Pleiotropic mechanisms facilitated by resveratrol and its metabolites. Biochem J 429:273-282.
8. Chan SL, Tabellion A, Bagrel D, Perrin-Sarrado C, Capdeville-Atkinson C, Atkinson J (2008) Impact of chronic treatment with red wine polyphenols (RWP) on cerebral arterioles in the spontaneous hypertensive rat. J Cardiovasc Pharm 51(3):304-310.
9. Colin D, Limagne E, Jeanningros S, Jacquel A, Lizard G, Athias A, Gambert P, Hichami A, Latruffe N, Solary E, Delmas D (2011) Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev Res 4(7):1095-1106.
10. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073-1081.
11. Csaki C, Mobasheri A, Shakibaei M (2009) Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: Inhibition of IL-1 beta-induced NF-kappa B-mediated inflammation and apoptosis. Arthritis Res Ther 11 (6).
12. Delmas D, Passilly-Degrace P, Jannin B, Cherkaoui-Malki M, Latruffe N (2002) Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med 10(2):193-199.
13. Delmas D, Rebe C, Lacour S, Filomenko R, Athias A, Gambert P, Cherkaoui-Malki M, Jannin B, Dubrez-Daloz L, Latruffe N, Solary E (2003) Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 278(42):41482-41490.
14. Delmas D, Solary E, Latruffe N (2011) Resveratrol, a phytochemical inducer of multiple cell death pathways: Apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18(8):1100-1121.
15. Ginsburg I, Kohen R, Koren E (2011) Quantifying oxidant-scavenging ability of blood. New Engl J Med 364(9):883-885.
16. Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Soleas G, Waterhouse AL (1995) A global survey of trans-resveratrol concentrations in commercial wines. Am J Enol Viticult 46(2):159-165.
17. Hassan-Khabbar S, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF, Conti M, Nivet- Antoine V (2008) Postischemic treatment by trans-resveratrol in rat liver ischemia-reperfusion: A possible strategy in liver surgery. Liver transpl 14(4):451-459.
18. Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, Cushman M (2010) Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem 53(13):5033-5043.
19. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425(6954):191-196.
20. Hua J, Guerin KI, Chen J, Michan S, Stahl A, Krah NM, Seaward MR, Dennison RJ, Juan AM, Hatton CJ, Sapieha P, Sinclair DA, Smith LE (2011) Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest Ophthalmol Vis Sci 52(5):2809-2816.
21. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP (2004) A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18(12):1450-1452.
22. Kosaka N, Ochiya T (2011) Unraveling the mystery of cancer by secretory microRNA: Horizontal microRNA transfer between living cells. Front genet 2:97.
23. Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K (2009) Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci 50(7):3512-3519.
24. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell 127(6):1109-1122.
25. Lancon A, Delmas D, Osman H, Thenot JP, Jannin B, Latruffe N (2004) Human hepatic cell uptake of resveratrol: Involvement of both passive diffusion and carrier-mediated process. Biochem Bioph Res Co 316(4):1132-1137.
26. Lancon A, Hanet N, Jannin B, Delmas D, Heydel JM, Lizard G, Chagnon MC, Artur Y, Latruffe N (2007) Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos 35(5):699-703.
27. Langcake P, Pryce RJ (1976) Production of resveratrol by vitis-vinifera and other members of vitaceae as a response to infection or injury. Physiol Plant Pathol 9(1):77-86.
28. Lee RC, Feinbaum RL, Ambros V (1993) The C-elegans heterochronic gene lin-4 encodes small Rnas with antisense complementarity to lin-14. Cell 75(5):843-854.
29. Lin HY, Lansing L, Merillon JM, Davis FB, Tang HY, Shih A, Vitrac X, Krisa S, Keating T, Cao HJ, Bergh J, Quackenbush S, Davis PJ (2006) Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J 20(10):1742-1744.
30. Losso JN, Truax RE, Richard G (2010) Trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J Agric Food Chem 58(14):8246-8252.
31. Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet 37(5):349-350.
32. Patel KR, Brown VA, Jones DJL, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K (2010) Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 70(19):7392-7399.
33. Pham-Marcou TA, Beloeil H, Sun X, Gentili M, Yaici D, Benoit G, Benhamou D, Mazoit JX (2008) Antinociceptive effect of resveratrol in carrageenan-evoked hyperalgesia in rats: Prolonged effect related to COX-2 expression impairment. Pain 140(2):274-283.
34. Renaud SC, Gueguen R, Schenker J, d'Houtaud A (1998) Alcohol and mortality in middle-aged men from Eastern France. Epidemiology 9(2):184-188.
35. Ritz MF, Ratajczak P, Curin Y, Cam E, Mendelowitsch A, Pinet F, Andriantsitohaina R (2008) Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J Nutr 138(3):519-525.
36. Shakibaei M, Csaki C, Nebrich S, Mobasheri A (2008) Resveratrol suppresses interleukin-1 beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: Potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76(11):1426-1439.
37. Shakibaei M, John T, Seifarth C, Mobasheri A (2007) Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro. Ann Ny Acad Sci 1095:554-563.
38. Sharma S, Chopra K, Kulkarni SK (2007) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide and TNF-alpha. Phytother Res 21(3):278-283.
39. Shen CL, Smith BJ, Lo DF, Chyu MC, Dunn DM, Chen CH, Kwun IS (2012) Dietary polyphenols and mechanisms of osteoarthritis. J Nutr Biochem 23(11):1367-1377.
40. Tili E, Michaille JJ (2011) Resveratrol, MicroRNAs, Inflammation, and Cancer. J nucleic acids 2011:102431.
41. Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM (2010) Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 31(9):1561-1566.
42. Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA (2007) miRNAs and their potential for use against cancer and other diseases. Future oncol 3(5):521-537.
43. Wang KT, Chen LG, Tseng SH, Huang JS, Hsieh MS, Wang CC (2011) Anti-inflammatory effects of resveratrol and oligostilbenes from Vitis thunbergii var. taiwaniana against lipopolysaccharide- induced arthritis. J Agric Food Chem 59(8):3649-3656.